Continuing Medical Education (CME) For Your Healthcare Team

Betting on BTK Inhibitors in CLL: Where are We Now and Where are We Going?
Click here to register
Exploring Biomarkers and Evolving Testing Strategies in NSCLC: A Case-Based Perspective to Precision Therapy
Click here to register
A New Frontier in Cancer Therapy: Examining the Role of PARP Inhibitors in an Emerging Paradigm
Complete Activity
Exploiting Deficiencies in the Tumor Genome: Expert Perspectives in the Era of PARP Inhibitors
Complete Activity
The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC
Complete Activity
Immune-Related Adverse Events with Cancer Immunotherapy: Case-Based Challenges for the Oncology Nurse
For more information on the regional chapter series click here
EGFR Resisters Inaugural Think Tank Proceedings and Call to Action
To read the proceedings and call to action click here
The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC
For more information on the regional chapter series click here
B-Cell Malignancies Tumor Board: Therapeutic Decision Making in Challenging Clinical Scenarios (Regional Chapters)
For more information on regional chapters click here
Expert Perspectives in The Era of PARP Inhibitors: Practical Applications for Your Ovarian Cancer Patients
For more information on the multi-modal grand rounds click here
B-Cell Malignancies Tumor Board: Therapeutic Decision Making in Challenging Clinical Scenarios
For more information on the grand rounds series click here

HomeSpiderSavvy2018-09-18T12:08:25-05:00

Upcoming Events

Exploiting Deficiencies in the Tumor Genome: Expert Perspectives in the Era of PARP Inhibitors

May 31, 2019 - May 31, 2020

A New Frontier in Cancer Therapy: Examining the Role of PARP Inhibitors in an Emerging Paradigm

June 17, 2019 - June 17, 2020

The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

July 31, 2019 - July 31, 2020

B-Cell Malignancies Tumor Board: Therapeutic Decision Making in Challenging Clinical Scenarios

November 13

Betting on BTK Inhibitors in CLL: Where are We Now and Where are We Going?

Exploring Biomarkers and Evolving Testing Strategies in NSCLC: A Case-Based Perspective to Precision Therapy

A New Frontier in Cancer Therapy: Examining the Role of PARP Inhibitors in an Emerging Paradigm

Exploiting Deficiencies in the Tumor Genome: Expert Perspectives in the Era of PARP Inhibitors

The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

Immune-Related Adverse Events with Cancer Immunotherapy: Case-Based Challenges for the Oncology Nurse

EGFR Resisters Inaugural Think Tank Proceedings and Call to Action

The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

B-Cell Malignancies Tumor Board: Therapeutic Decision Making in Challenging Clinical Scenarios (Regional Chapters)

Expert Perspectives in The Era of PARP Inhibitors: Practical Applications for Your Ovarian Cancer Patients

B-Cell Malignancies Tumor Board: Therapeutic Decision Making in Challenging Clinical Scenarios

Upcoming Events

Exploiting Deficiencies in the Tumor Genome: Expert Perspectives in the Era of PARP Inhibitors

May 31, 2019 - May 31, 2020

A New Frontier in Cancer Therapy: Examining the Role of PARP Inhibitors in an Emerging Paradigm

June 17, 2019 - June 17, 2020

The Changing Face of Lung Cancer: Exploring Recent Advances in Precision Medicine for EGFR-Mutated NSCLC

July 31, 2019 - July 31, 2020

B-Cell Malignancies Tumor Board: Therapeutic Decision Making in Challenging Clinical Scenarios

November 13